Estimated onset age of CSF amyloid and tau accumulation and relationship to clinical outcomes

Abstract

Background: Neuropathological studies indicate AD pathology is present in midlife. Few studies, however, have examined the onset of AD biomarker changes, simultaneously for amyloid and tau, starting in midlife.

The paper